textabstractAbstract BACKGROUND: We have treated three patients with carboxy-anhydrase-IX (CAIX) positive metastatic renal cell cancer (RCC) by adoptive transfer of autologous T-cells that had been gene-transduced to express a single-chain antibody-G250 chimeric receptor [scFv(G250)], and encountered liver toxicity necessitating adaptation of the treatment protocol. Here, we investigate whether or not the in vivo activity of the infused scFv(G250)(+) T cells is reflected by changes of selected immune parameters measured in peripheral blood. METHODS: ScFv(G250)-chimeric receptor-mediated functions of peripheral blood mononuclear cells (PBMC) obtained from three patients during and after treatment were compared to the same functions of scFv(...
Lymphocytes are a key component of the immune system and their differentiation and function are dire...
In order to test the effectiveness of adoptive immunotherapy against renal cell carcinoma (RCC) in a...
BACKGROUND: Evidence suggests that some patients with renal cell carcinoma (RCC) respond to immunomo...
PURPOSE: CD4(+)CD25(+) regulatory T (T(reg)) cells are present in increased numbers in patients with...
textabstractTherapy with autologous T cells that have been gene-engineered to express chimeric antig...
The successful use of expanded tumor-infiltrating lymphocytes (TIL) in adoptive TIL therapies has be...
Purpose: Transforming growth factor-beta (TGF-beta) is a potent immunosuppressor that has been assoc...
Adoptive transfer of immune effector cells that are gene modified by retroviral transduction to expr...
Lymphocytes are a key component of the immune system and their differentiation and function are dire...
<div><p>Lymphocytes are a key component of the immune system and their differentiation and function ...
The chimeric monoclonal antibody cG250 targets the G250 antigen, a transmembrane protein which is ex...
PURPOSE: Adoptive therapy with genetically engineered T cells carrying redirected antigen specificit...
Tumor-induced immunosuppression remains a major challenge for immunotherapy of cancer patients. To f...
textabstractPurpose: Immune responses to gene-modified cells are a concern in the field of human gen...
Background: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in canc...
Lymphocytes are a key component of the immune system and their differentiation and function are dire...
In order to test the effectiveness of adoptive immunotherapy against renal cell carcinoma (RCC) in a...
BACKGROUND: Evidence suggests that some patients with renal cell carcinoma (RCC) respond to immunomo...
PURPOSE: CD4(+)CD25(+) regulatory T (T(reg)) cells are present in increased numbers in patients with...
textabstractTherapy with autologous T cells that have been gene-engineered to express chimeric antig...
The successful use of expanded tumor-infiltrating lymphocytes (TIL) in adoptive TIL therapies has be...
Purpose: Transforming growth factor-beta (TGF-beta) is a potent immunosuppressor that has been assoc...
Adoptive transfer of immune effector cells that are gene modified by retroviral transduction to expr...
Lymphocytes are a key component of the immune system and their differentiation and function are dire...
<div><p>Lymphocytes are a key component of the immune system and their differentiation and function ...
The chimeric monoclonal antibody cG250 targets the G250 antigen, a transmembrane protein which is ex...
PURPOSE: Adoptive therapy with genetically engineered T cells carrying redirected antigen specificit...
Tumor-induced immunosuppression remains a major challenge for immunotherapy of cancer patients. To f...
textabstractPurpose: Immune responses to gene-modified cells are a concern in the field of human gen...
Background: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in canc...
Lymphocytes are a key component of the immune system and their differentiation and function are dire...
In order to test the effectiveness of adoptive immunotherapy against renal cell carcinoma (RCC) in a...
BACKGROUND: Evidence suggests that some patients with renal cell carcinoma (RCC) respond to immunomo...